Close
Nordic 9Nordic 9

Claris Ventures (investor - Venture Capital)

Italy clarisventures.com
See something wrong or missing? Let us know
Offices:Turin

Claris Ventures is a venture capital firm from Italy focused on early-stage investments in high potential biopharma companies.

Average round investment:11.73M USD
Average number per year:2.4
Distribution: 2025 (3)2024 (1)2023 (4)2022 (3)2021 (1)
Portfolio companies: Italy Haptena TherapeuticsItaly Lever BioItaly IAMA Therapeutics See the entire list
Mostly invests in: Italy Italy (9) Health services (10)
See the entire list

Showing 3 of 12 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Claris Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Claris Ventures

Name Criteria
United States Day One Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United Kingdom Celsius Industries
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United Kingdom PDS Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
France Monte Carlo Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Luxembourg i&i Biotech Fund
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Saras Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom BP Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Italy Ithaca Investments
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Italy, United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United Kingdom Concentric
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Belgium Novalis Biotech
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top